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METHOD ARTICLE
   Detecting variable responses in time-series using
repeated measures ANOVA: Application to physiologic
 challenges [version 2; referees: 2 approved]
Paul M. Macey ,   Philip J. Schluter , Katherine E. Macey , Ronald M. Harper4
UCLA School of Nursing, LA, CA, USA
Brain Research Institute, Department of Neurobiology, David Geffen School of Medicine, UCLA, LA, CA, USA
School of Health Sciences, University of Canterbury, Christchurch, New Zealand
Department of Neurobiology, David Geffen School of Medicine, UCLA, LA, CA, USA
Abstract
We present an approach to analyzing physiologic timetrends recorded during a
stimulus by comparing means at each time point using repeated measures
analysis of variance (RMANOVA). The approach allows temporal patterns to be
examined without an model of expected timing or pattern of response.a priori 
The approach was originally applied to signals recorded from functional
magnetic resonance imaging (fMRI) volumes-of-interest (VOI) during a
physiologic challenge, but we have used the same technique to analyze
continuous recordings of other physiological signals such as heart rate,
breathing rate, and pulse oximetry. For fMRI, the method serves as a
complement to whole-brain voxel-based analyses, and is useful for detecting
complex responses within pre-determined brain regions, or as a post-hoc
analysis of regions of interest identified by whole-brain assessments. We
illustrate an implementation of the technique in the statistical software
packages R and SAS. VOI timetrends are extracted from conventionally
preprocessed fMRI images. A timetrend of average signal intensity across the
VOI during the scanning period is calculated for each subject. The values are
scaled relative to baseline periods, and time points are binned. In SAS, the
procedure PROC MIXED implements the RMANOVA in a single step. In R, we
present one option for implementing RMANOVA with the mixed model function
“lme”. Model diagnostics, and predicted means and differences are best
performed with additional libraries and commands in R; we present one
example. The ensuing results allow determination of significant overall effects,
and time-point specific within- and between-group responses relative to
baseline. We illustrate the technique using fMRI data from two groups of
subjects who underwent a respiratory challenge. RMANOVA allows insight into
the timing of responses and response differences between groups, and so is
suited to physiologic testing paradigms eliciting complex response patterns.
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Introduction
We describe a procedure for analyzing physiologic signals recorded 
during a stimulus at each time point across multiple subjects 
without an a priori pattern or timing of expected response. The con-
cept is to average the signal overall stimuli and over subjects, and 
look at differences between groups and conditions, especially the 
interaction with time since onset. The time of onset is treated as a 
baseline that is followed by one or more stimuli and recovery peri-
ods, a paradigm common to physiologic challenges. Because the 
challenges are clustered within subjects, the data are modeled with 
a mixed linear model. The result is a figure with the average time 
course per group/condition, with a statistical test comparing the signal 
at each time point. The model tested is then SIGNAL = GROUP + 
TIME + GROUP*TIME. Other covariates may be added. Impor-
tantly, the TIME variable is modeled as categorical, not continuous. 
Modeling time as categorical allows tests for each time point to be 
performed separately in post-hoc testing. The results of interest are 
the post-hoc tests of the interaction effect between group and time.
We initially designed this approach to analyze functional MRI 
(fMRI) time series recorded during gas and blood pressure chal-
lenges, such as hyperoxia, cold pressor, and Valsalva tests1–3. 
The protocol for such tests is the typical “boxcar” model, with a 
baseline period followed by one or more challenges, followed by 
recovery periods. We subsequently applied the method to heart rate 
and respiratory signals recorded during physiologic challenges4. 
Functional MRI analyses usually require defining a model and 
identifying voxels whose time courses follow that model; other 
model-free event-related approaches test for responses that are 
coincident in time or duration. However, certain tasks elicit neural 
responses that vary in pattern and timing. For example, responses 
to physiological challenges typically occur across neural structures 
in a sequence rather than simultaneously, and the patterns are not 
“on/off” but differ according to structure5–7. While existing software 
like SPM does allow for model-free assessment of responses, such 
as identifying the hemodynamic response based on a finite impulse 
response function in SPM8, those approaches can be complex to 
implement and interpret, especially for multiple groups and longer 
challenges. The present method arose out of our need to perform 
basic time-trend analyses of fMRI signals in specific regions.
We first developed the approach to better understand the nature 
of differences detected by traditional whole-brain fMRI analyses 
such as implemented in SPM. Typical whole-brain results consist 
of significance maps indicating areas of signal increase or decrease, 
or perhaps of group differences, but identifying the exact nature 
of such differences requires extracting and analyzing underly-
ing timetrends. In other words, SPM gave us “blobs” where brain 
function had varied from baseline, but we wanted to know exactly 
how and when those fMRI responses changed. In physiologic regu-
lation, timing is critical, and we aimed to identify specific time-
points at which fMRI signals significantly increased or decreased 
following a challenge, and points at which group differences 
emerged.
The approach we propose is analyzing time series using repeated 
measures analysis of variance (RMANOVA), allowing for detec-
tion of within-group responses relative to a baseline or resting state, 
and of between-group differences in response. As with any analy-
sis of variance (ANOVA), RMANOVA tests the equality of means 
that are assumed to be normally distributed. However, RMANOVA 
also accounts for the correlation between repeated measures within 
subjects, whereas ANOVA does not. In addition to assessment of 
significant reactions relative to a baseline period, or of significant 
group differences in response, the method allows for identifying 
specific time-points when these differences occur. Therefore, tran-
sient, late-developing, and complex sequences of increasing and 
decreasing signal changes can be distinguished with RMANOVA. 
The technique is suited to analysis of longer task paradigms evok-
ing a complex pattern of responses. We present implementations of 
this form of RMANOVA in R (https://www.r-project.org/) and SAS 
(SAS Institute Inc., Cary, NC).
Description of procedure
Functional MRI data collected in one or more groups of subjects are 
preprocessed, typically with motion correction, and the images 
may be spatially normalized. An additional, optional step is 
detrending to remove global effects. In traditional cluster analyses, 
global effects may be accounted for within the analysis steps using, 
for example, SPM9. For the example data, removal of global signal 
changes was performed on the preprocessed images prior to analysis 
with RMANOVA using a custom technique10. Physiologic data that 
are direct measures such as heart rate do not need preprocessing.
For fMRI analyses, volumes-of-interest (VOI) are defined, usually 
by outlining a structure of interest on an image volume and saving 
that outline as a binary image, or mask. The VOI may be defined 
individually on a subject-by-subject basis, or globally for all sub-
jects on a template (the latter case assumes subjects’ images are 
accurately spatially normalized to the template). The mask is used 
to extract the intensity of only those voxels within the VOI, at each 
time point in the fMRI series. For each time point, the average 
of those voxel values is recorded, resulting in a time-series cor-
responding to the blood oxygen level dependent (BOLD) signal 
time course of that VOI in the fMRI series. The procedure is 
repeated for all subjects, resulting in one time trend for each subject 
per VOI. The time trends may optionally be deconvolved with a 
hemodynamic response function (HRF), allowing the timing of 
significant responses to be inferred as neural, rather than BOLD. 
The resulting VOI time trends are subjected to a RMANOVA. 
Physiologic data measured at non-uniform intervals may need to be 
resampled so that each subject has a measure at equivalent time 
points.
The repeated measures ANOVA is using a mixed effect model, a 
generalization of the standard linear model which allows for cor-
relation and non-constant variability within the data11. Common 
RMANOVA implementations such as “aov” in R and “ranova” in 
MATLAB require the same number of measurements for each time 
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bin, which is not always possible with data from physiologic chal-
lenges. In the mixed model implementation of RMANOVA, each 
subject is included as a random factor, together with a covariance 
structure that accounts for repeated measures. The methodology 
described here was originally based on the SAS function PROC 
MIXED, and extended to the R procedure “lme” in the “nlme” 
library. The SAS approach is flexible, and includes a wide range 
of diagnostics tests. (See white paper “Comparing the SAS® GLM 
and MIXED Procedures for Repeated Measurements Analysis,” 
Russ Wolfinger and Ming Chang, SUGI Proceedings, 1995; 
available at https://support.sas.com/rnd/app/stat/papers/abstracts/
mixedglm.html.) The procedures calculate the variance-covariance 
matrix based on the dependencies defined by repeated measure-
ments within subjects, and by group classification of subjects in 
the case of more than one group (REPEATED and GROUP options 
within PROC MIXED; by convention, SAS syntax is in upper 
case)11. There is no R equivalent of PROC MIXED, so a series of 
functions are required. The “lme” function is more limited than 
PROC MIXED, but nevertheless is sufficient for implementing the 
core model in the present application.
A classification variable (t) representing baseline and time-points 
in the task or challenge period is created, with values of t during 
the baseline or reference period constant, and values increasing for 
each time point in the series. For example, we have collected fMRI 
data during physiological challenges with one minute of baseline 
followed by 90 sec of challenge, at a repetition time of 6 seconds 
(25 volumes total); thus, t is 0 for the first 10 scans, and 1 for the 
11th volume, 2 for the 12th, and so on until 15 for the 25th. Note that 
for data collected at higher sampling rates or across longer time 
periods, the time bins may be increased, and the time-classification 
variable may include multiple data points, as opposed to the indi-
vidual data points of the fMRI time-series; for example, we have 
classified instantaneous (beat-by-beat) heart rates recorded 
throughout a two minute period into twelve 10 sec epochs12. If more 
than one group of subjects is being analyzed, a second classifica-
tion variable is defined at each time point with a value representing 
the group to which that series belongs. The data format therefore 
consists of column variables of the response, time bin, subject, 
group, and optionally other covariates. Note this format differs 
from simpler implementations of RMANOVA which require one 
row with responses for all time bins.
Before assessing the time-trend results of the RMANOVA analysis 
(see sections below for full details), certain residual and influence 
diagnostic tests should be performed to ensure that the model does 
not seriously violate underlying assumptions. A relevant subset of 
such tests is described in sections below. Many practical applica-
tions of RMANOVA violate the model assumptions to some degree, 
but the approach is considered robust to moderate departures of 
these assumptions. In the present application to physiologic data, a 
key test is to ensure that the residual distributions are not seriously 
skewed. We suggest the flowing checks. First determine the studen-
tized residuals, which are scaled so that more than 95% should fall 
within the critical limits of the appropriate Student’s t distribution, 
which for most purposes can be assumed to be within ± 1.96 (and 
centered on 0). The shape of the histogram for each group of the 
studentized residuals should be bell-shaped. There should also be 
no effect of time, so each group plot of the studentized residuals 
by time should not show a trend. We recommend using locally-
weighted-scatter-plot (lowess) curves to identify such trends. In the 
case where the diagnostic tests fail, there may still be some value in 
continuing with the model, but we suggest presenting the results of 
the residual diagnostics along with the findings, to allow readers to 
assess for themselves the validity of the model. Further options are 
explained below, along with other diagnostic tests. Because these 
tests are closely tied with the software implementation, they are 
described in conjunction with the code.
There are three levels of results produced by RMANOVA: the 
significance of the overall model, the significance of the independ-
ent variables and their interactions at the group, time, and group- 
by-time levels, and (for post-hoc testing) the significance of 
between-group and within-group effects at each time point. The 
sequence is to test 1) global fit of the model; if significant then 
test 2) variable and interaction level fit; and if significant test 
3) post hoc at individual time points. That is, by the Tukey-Fisher 
criterion for multiple comparisons, the model is first assessed 
for overall significance before investigating time-point specific 
effects; i.e., if the overall group-by-time effect is not significant, 
the between-group effects at each time point are not considered, 
regardless of their reported significance level. Similarly, if the 
overall time effect is not significant, then within-group effects at 
each time point are not considered.
Specific programming details are presented in the next sections to 
facilitate replication.
Text file format for exporting to R and SAS
Data are arranged in columns with one row per observation. Each 
row has the time bin (“epoch”), response value (“y”), and subject. 
For more than one group, a group value is required, and addi-
tional covariates can also be included. Each subject is identified 
by a unique classification variable (SUBJECT), and similarly, the 
group to which that subject belongs is designated by a GROUP 
classification variable e.g., 1, 2, or CONTROL, OSA). For any 
subject, multiple values for each epoch may be included, and dif-
ferent numbers of observations for each epoch are allowed; the 
baseline will usually have the most observations. Values for fMRI 
are typically in percentage change relative to the baseline period.
The SAS code for importing these data in a text file “fn” with a 
header row into a library “voilib” is as follows:
LIBNAME voilib ‘[sas_library_folder]’;
PROC IMPORT OUT=voilib.data
DATAFILE = ‘[fn]’
DBMS=TAB REPLACE;
GETNAMES=YES;
DATAROW=2;
RUN;
here [sas_library_folder] is the path to where the SAS library 
files will be stored. Note that SAS code is not case dependent. In 
the examples presented here, capitals are used to indicate SAS 
commands, and bolded names within square brackets are used to 
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indicate user-specified variables. The remaining lowercase names 
are variables specific to these examples.
The R code is as follows:
setwd(“[R_library_folder]”)
voidat <- read.table(“[fn]”, sep=“\t”, header=TRUE)
RMANOVA as mixed model
The SAS RMANOVA, along with formatting and output filtering, is 
implemented as follows:
PROC MIXED noitprint noclprint data= voilib.data empirical;
class group epoch subject; 
model y = group epoch group*epoch / outp = prediction RESIDUAL;
repeated / type=cs sub=subject(group) group=group;
lsmeans group*epoch / DIFF;
ods listing exclude lsmeans;
ods output lsmeans= voilib.means;
ods listing exclude diffs;
ods output diffs=voilib.differences;
ods output CovParms= voilib.covparams;
ods output FitStatistics= voilib.fitstatistics;
ods output Tests3= voilib.type3tests;
RUN;
where the italicized statements define the model, and the remaining 
control the output (including residuals). Note that the RESIDUAL 
option, which directs studentized residuals to be calculated, is 
only available from SAS version 9.1. The CLASS statement deter-
mines classification variables. The EMPIRICAL option in the proc 
mixed command line uses the Huber-White sandwich estimator 
of variance, rather than the default, as it is more conservative but 
considered more robust, particularly if the assumption of normality 
is violated (as is often the case).
The R model first requires converting the classification variables to 
factor objects:
fmridat <- within(fmridat, {
epoch <- factor(epoch) # time was continuous but for RMANOVA 
must be categorical
subject <- factor(subject)
group <- factor(group)
})
The mixed model is then implemented in lme with the option to fit a 
random intercept per subject, which is equivalent to PROC MIXED 
with compound symmetric covariance matrix.
library(nlme)
out.lme <- lme(y~group*epoch, random = ~1 | subject, data= 
fmridat)
Although other covariance matrices other than compound sym-
metric might in theory be more suited to the present application, 
in our tests with SAS we found greatly increased computational 
time for minimal differences in results (for example with compound 
symmetric heterogeneous), so the proposed option in R should be 
suitable for the current application.
In SAS, the output from this step contains numerous descriptors 
of the model. The “Null Model Likelihood Ratio Test” gives the 
probability of the null model being true (column heading 
“Pr > ChiSq”). If the model passes the Tukey-Fisher criterion for 
multiple comparisons, i.e., the probability of the null model is less 
the 0.05, the model is investigated at the variable level using the 
“Type 3 Tests of Fixed Effects’ output. Probabilities of the null con-
tribution to the model by individual independent variables are pre-
sented in the “Pr > F” column for the group, epoch and group*epoch. 
“Group” represents a group effect, which is often not significant for 
fMRI data presented in percent change relative to baseline. The vari-
able epoch represents a time effect, corresponding to within-group 
significant responses. The group*epoch term represents a group-
by-time effect, corresponding to between-group differences across 
time. Again considering the Tukey-Fisher criterion, if for any of 
these variables the likelihood of the null model is greater than 0.05, 
then that variable is determined to be not significant. If less than 
the threshold, the model is investigated further at each time point.
For R, further commands are required to generate equivalent statis-
tics. The “summary(out.lme)” will provide global level fit statistics 
(at the start of the output listing). The ANOVA table created with 
“anova(out.lme)” will provide the separate group, group*epoch, 
and epoch statistics.
Further code is needed to select the relevant output for deter-
mining the time points of within and between group significant 
differences. The SAS code below is one of several possible ways to 
extract the relevant results.
The following command keeps all comparisons at the same 
epoch, hence the between-group table. The SORT step orders the 
table.
DATA voilib.betweengroup; SET voilib.differences;
IF epoch ne _epoch THEN delete;
DROP _epoch;
RUN;
PROC SORT DATA= voilib.betweengroup; BY epoch group; 
RUN;
The following command extracts the within group table. Between 
group comparisons are dropped, and only those relative to baseline 
(epoch 0) are kept. The SORT step orders the table.
DATA voilib.withingroup; SET voilib.differences;
IF group NE _group THEN delete;
DROP _group;
IF epoch NE 0 THEN delete;
Page 5 of 23
F1000Research 2016, 5:563 Last updated: 15 AUG 2016
ROC SORT DATA= voilib.withingroup; BY group _epoch; 
RUN;The above code will create Withingroup and Betweengroup 
tables in the SAS library voilib.
In R, the “Post-Hoc Interaction Analysis” (phia) simplifies the 
equivalent process. For between-group tests at each epoch the fol-
lowing code will export the results to a text file.
library(phia)
num_group <-length(unique(fmridat$group))
if (num_group>1) {
  # Between group is easy
  bg <- testInteractions(out.lme,pairwise=“group”,fixed=“epoch”)
  write.table(bg,file = “betweengroup.txt”, sep = “\t”)
}
The withingroup results require extracting only the differences 
of non-baseline epochs relative to the baseline (epoch=0), within 
groups. The following code is one approach.
library(phia)
wg <- testInteractions(out.lme,pairwise=“epoch”,fixed=“group”)
# However, only interested in responses wrt baseline, so extract 
epoch 0 vs others.
# E.g., we are not interested in comparison between epoch 5 and 
10.
# Number of time bins
num_epoch <- length(unique(fmridat$epoch))
grouplist = unique(fmridat$group)
# Use the “data.table” alternative to R frame - apparently faster, less 
memory intensive, and simpler coding.
library(data.table)
dattable = data.table(fmridat)
# The number of subjects is calculated for each group.
# Initialize vector (required by R)
num_subjects <- vector(mode=“numeric”, length=num_group)
for (i in 1:num_group) {
groupdat <- dattable[group == grouplist[i]]
num_subjects[i] <- length(unique(groupdat$subject))
}
# Create logical vector to isolate the first entries (epoch 0 vs...) for 
each group
# The “wg” withingroup table has all combinations of epochs for 
each group
# Calculate the number of combinations
num_epochcomb <- choose(num_epoch,2)
# Initialize true/false vector; default is false
ind2baseline_wg <- vector(mode = “logical”, length= 
num_group*num_epochcomb)
row_upto <- 1
for (i in 1:num_group) {
row_1 = row_upto;
row_2 = row_upto + num_epoch-2;
ind2baseline_wg[row_1:row_2] <- TRUE
row_upto <- row_upto + num_epochcomb
}
# Using logical vector, create table with only epoch 0 vs others (for 
each group)
wgb <- wg[ind2baseline_wg,]
write.table(wgb,file = “withgroup.txt”, sep = “\t”)
If “epoch” showed a significant effect in the Type 3 tests (above), 
the time points where this difference appeared may be determined 
by examining the withingroup table. As shown in Figure 1, each 
row in the table compares baseline (labeled “epoch”) vs subsequent 
epochs (labeled “vs epoch”), with a mean difference, standard 
error and P value; if the latter indicates significance (< 0.05), that 
time point is considered to have a significant response relative to 
baseline for that group.
Similarly, if “group*epoch” showed a significant effect in the Type 3 
tests (above), the time-points where this difference appeared may 
be determined by examining the Between group table. As shown in 
Figure 2, each row corresponds to a time point (labeled “epoch”) 
Figure 1. Example of within-group table of time-points of difference relative to baseline (epoch 0).
Figure 2. Example of between-group table of time-points of difference between groups.
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and compares one group vs the other, with a mean difference, 
standard error and P value; if the latter indicates significance 
(< 0.05), that time point is considered to have a significant group 
difference.
Assumptions, diagnostic checks, and limitations
The RMANOVA method has a number of underlying assumptions 
which should be considered. The assumptions of the RMANOVA 
method presented here which differ from ANOVA are that 1) the 
means are linear over time, 2) multivariate normality, 3) homoge-
neity of covariance matrices, and 4) independence. The method is 
reasonably robust to violations of the second and third assump-
tions. Violations of independence result in non-normal distributions 
of the residuals, which invalidate the F-ratio. While violations of 
independence in time series regression models arise due to correla-
tions between errors at different time points, in RMANOVA the 
problem would arise if the model systematically over- or under-
predicts for particular independent variable values. The most 
common violations of independence occur when either random 
selection or random assignment is not used or the compound sym-
metry covariance assumption is inappropriate. Violation of the 
homogeneity of covariance matrices generally results in the overall 
test having a higher Type I error rate than nominally set.
In the current application, a subset of key diagnostic and residual 
checks is suggested with the implementation of this technique.
• Plots of predicted and observed data, to visually determine 
any major bias.
• Residual checks of normality, including 95% of Studen-
tized residuals falling within ±1.96, showing approxi-
mately normal group distributions, and scatter plots over 
time with lowess curves superimposed to ensure lack of 
group trends with time. Formal tests of normality may also 
be performed, although these will typically fail.
Assuming the “RESIDUAL” option in PROC MIXED has been 
used, the output will show these plots.
The quantitative tests of normality in the proc univariate results 
give likelihoods of the each variable being normally distributed; for 
multivariable normality, all variables should be normally distrib-
uted, although this assumption is usually violated to some degree. 
The output of the UNIVARIATE procedure includes histograms of 
residuals (for assessing whether shape of distribution is approxi-
mately normal) and side-by-side box plots of residual distribu-
tion by group (Figure 3 and Figure 4). In R, the lme object has 
Figure 3. Plot of residuals for one group.
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Figure 4. Box plot of residuals for both groups.
diagnostic plot methods including boxplots, by subject and by 
group in the following examples:
plot(out.lme, subject ~ resid(.)) # by subject
plot(out.lme, group ~ resid(.)) # by group
Tests of influence
Further possible tests include influence diagnostics to determine 
whether particular subjects have undue effect on the model. If 
undue bias due to individual subjects is suspected, the approach we 
suggest is to use the influence measures to investigate whether 
one or more subjects are consistently and substantially discrepant 
from the others. In SAS these tests may be run by adding the 
INFLUENCE statement [e.g., after in PROC MIXED after 
“RESIDUAL” add “INFLUENCE(EFFECT=subject ITER=5)” 
and ODS SELECT INFLUENCE]; note that this requires SAS 
version 9.1 or greater. This test produces the restricted likelihood 
distance, predicted residual sum of squares (PRESS) statistic, and 
Cook’s distance (known as Cook’s D) for each subject. In R, one 
option is to use the “predictmeans” package to calculate Cook’s D 
and display the standardized residuals, and the PRESS statistic may 
be calculated directly from residuals predicted using the original 
data, as shown below.
library(predictmeans)
CookD ( out.lme, group = “subject” ) # where out.lme <- lme(…)
residplot(out.lme)
pr <- residuals(out.lme)/(1 - predict(out.lme,dat2))
press <- sum(pr^2)
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At the time of writing, there is no equivalently simple R function to 
calculate studentized residuals for an lme mixed model.
If a discrepant subject is found, an attempt can be made to deter-
mine whether there is some reason for this. If a reason can be 
found, then they might legitimately be excluded. A “sensitiv-
ity” analysis may be run (a comparison analysis including and 
excluding that patient) to see if there is a material difference in the 
conclusions or results of interest. In SAS, the homogeneity of cov-
ariance matrices can also be assessed in a similar manner using 
the ESTIMATES option in the INFLUENCE statement. Although 
these influence diagnostics may be useful in some cases, they have 
less relevance in fMRI analyses due to the controlled nature of 
typical experiments and are presented here as optional.
Options if diagnostic tests fail
If the residuals are non-normal but symmetrical around 0 then the 
model is probably robust. However, if the residuals are both non-
normal and non-symmetrical (i.e., skewed) then estimate biases 
may appear. For a large number of patients or observations, results 
are typically robust to moderate amount of skew. For smaller 
numbers, even a smaller amount of skew will mean the model is 
unlikely to be robust. If the data are seriously skewed, the typical 
options include making transformations (log, power transforma-
tions, etc.), identifying and omitting unusual patients (see above), 
using another more appropriate analytical technique, introduce 
covariates into the model, or not analyze the data. For fMRI stud-
ies, omitting unusual patients and adding covariates are the most 
likely approaches. As mentioned earlier, if the findings from 
the model are considered of value, then we suggests researchers 
report them along with the diagnostics test results so that the 
reader can assess for themselves the validity of the results.
Additional limitations
RMANOVA has additional limitations which may be less appli-
cable to fMRI data, but are detailed below for completeness. 
The constraints of the assumptions result in weaknesses of the 
approach, including:
• Missing time bin data, potentially relevant to non-
fMRI data such as beat-by-beat measures of heart rate, 
requires cases to be deleted from the analysis, causing 
both conceptual and analytical difficulties. Imputation 
methods can be employed to circumvent this issue. 
However, for any time bin subjects may have differing 
numbers of responses. For example, at “epoch 5” 
subject 1 may have a single response whereas subject 2 
may have three measures; such a scenario could occur 
with breath-by-breath respiratory rate responses.
• Tests of within-subjects effects assume sphericity, but 
this was not directly evaluated. The data can be tested for 
sphericity, but this evaluation is complex within the proc 
mixed framework, and is not addressed here. In theory, 
Mauchly’s test of spherericity can be used, for example, 
when any within-subjects factor has three or more trials. 
(If the within-subject factor fails to meet the assumption 
of sphericity, then either the multivariate approach can 
be used or the univariate results can be adjusted using 
a correction factor, e.g., the Huynh-Feldt Epsilon 
correction method [the Greenhouse-Geisser method has 
been shown to be too conservative]).
• The choice of the within-subject correlation matrix form 
is dependent upon sphericity assumptions, and we suggest 
a compound symmetric matrix (“type = cs” option in proc 
mixed; random intercept per subject as suggested for R 
is equivalent) to allow for different variance patterns 
across groups. If different variance patterns across time 
are suspected, then heterogeneous compound symmetry 
could be used (“type = csh” option in SAS; not available 
with suggested R implementation). However, this process 
is extremely computationally intensive, and in tests we 
performed, made no notable difference to the fit of the 
model.
Finally, in SAS the library voilib created with the above code 
contains numerous tables of data including predicted values, obser-
vations, model fit statistics, and residuals. These tables can be 
examined further.
Implementation and results
Test data and subjects
We used fMRI data collected from two obstructive sleep apnea and 
two healthy control subjects as part of a pilot project; data are avail-
able online9. The data were chosen to illustrate the RMANOVA 
methodology, and do not constitute a sample that is sufficient to 
test scientific hypotheses. The Institutional Review Board of UCLA 
approved this study (IRB# 10-001012), which was in compliance 
with the Declaration of Helsinki; participants provided informed, 
written consent after the nature of the procedures was explained. 
Following a baseline scanning period, subjects performed a series 
of four respiratory challenges (30 s maximal inspiratory apnea), 
which were expected to elicit abnormal physiological responses 
in the patient group, based on earlier demonstrations of impaired 
neural responses to physiologic challenges1,13–15. A standard fMRI 
whole-brain protocol with repetition time of 2.5 s was imple-
mented on a 3T Siemens Trio MRI scanner, and high-resolution 
T1-weighted anatomical scans were also collected (voxel size = 
0.9 × 0.9 × 1 mm). The fMRI data were preprocessed using SPM 
routines, including realignment, spatial normalization, and smooth-
ing. Smoothed images were intensity normalized to minimize 
global effects. VOI derived from the “AAL” toolbox in SPM were 
used to extract timetrends from the processed data16, and eight 
were selected to illustrate a variety of patterns highlighted by 
the approach. For each VOI, the time-series were analyzed using 
RMANOVA across the groups of two subjects, with challenges 
combined. Accompanying SAS and Excel files for each VOI are 
included online with this publication (Data availability).
Dataset 1. Processed data, as well as the SAS code for running 
each VOI analysis
http://dx.doi.org/10.5256/f1000research.8252.d117479 
Organised as subfolders for each VOI, labeled by figure section. 
The VOI itself is also included as a nifti file, and in a pdf file overlaid 
onto a normalized background.
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Figure 5. Average time trends for a control and patient group, averaged over four breath-hold challenges (30 s maximal inspiratory 
apnea), from eight VOI. VOI are from the Automatic Anatomical Labelling toolbox extension to SPM. Time-points of between and within-group 
significant responses relative to baseline period are indicated by color-coded “*” symbols. The graphs are in percent signal change relative 
to baseline, and each trace is a group/challenge average (± between-subject SE).
Preprocessing was performed using MATLAB 7 (The Mathworks, 
Inc., Natwick, MA, USA), SPM (http://www.fil.ion.ucl.ac.uk/spm/) 
and a custom detrending routine10. VOI were drawn using MRIcroN 
software17, and RMANOVA was implemented in SAS 9.411.
Evaluation of fMRI responses, within and between groups
A set of results is presented in Figure 5, illustrating a variety of 
statistical responses for eight VOI within the same fMRI dataset. 
This section describes the analytic steps needed to arrive at these 
results.
Residual tests of the RMANOVA assumptions. Several diagnostic 
tests were performed. The predicted responses were similar to 
the observed responses. Distributional tests of the Studentized 
residuals tests determined that the data were not precisely normally- 
distributed, as determined by the statistical tests with the PROC 
UNIVARIATE procedure. However, over 95% of the residu-
als were within ± 1.96, and visual inspection of the plots of 
residuals and predicted versus observed values showed only minor 
skew, and therefore the data were considered to be adequately 
modeled by the RMANOVA.
Within and between-group responses highlighted by RMANOVA. 
We analyzed the fMRI signal responses. To infer neuronal responses 
that lead to the BOLD phenomenon that is measured by the 
fMRI signal, the patterns should be deconvolved with an HRF; 
this approach was not applied here.
The Tukey-Fisher criterion for multiple comparisons All VOI 
showed significance effects of the RMANOVA models at the 
global level (Figure 5A–H), so in line with the Tukey-Fisher cri-
terion for multiple comparisons, the independent variables and 
interactions were assessed. If any model was not significant at the 
global level, no further post-hoc assessments would have been 
performed, even if specific time-points showed significance. For 
the right mid cingulate (Figure 5F), the group×time interaction was 
not significant, so no post hoc tests were performed on between-
group time point effects. All VOI showed significant effects of 
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“epoch” so within-group time points were assessed post hoc for 
all groups.
The three VOI in Figure 5A–C would likely all be highlighted 
as having significant group differences in response using con-
ventional SPM analyses. However, RMANOVA provides more 
detail on when and how the groups differ. Figure 5A illustrates a 
typical fMRI pattern of difference, with one group showing 
increased signal throughout the challenge, and the other group 
essentially no change. Figure 5B illustrates an opposite response 
between the groups, with on increasing and the other decreasing 
during the challenge period. Figure 5C shows a decrease in one 
group with no change in the other.
Figure 5D illustrates a simple case of a similar change in both 
groups; thus the within-group timepoints of difference are 
highlighted during the challenge period, corresponding to an 
equivalent decrease in OSA and control subjects. Figure 5E shows 
both groups changing in the same direction, but with a greater 
magnitude of response in the OSA group, thus leading to significant 
between-group differences across multiple time-points. Figure 5E 
also illustrates a pattern of changes that lasts over 30 seconds into 
the recovery period.
Transient differences are shown in Figure 5F–H. Figure 5F 
shows a pattern of initial increased response in the OSA group and 
sustained decreased response in the control group. However, unlike 
previous examples, the trends in the OSA group change 10–15 
seconds into the challenge from an increase to a decrease below 
baseline. Figure 5G shows a an opposite pattern in control sub-
jects (initial decrease, latter increase), and in OSA two large peaks 
are identified as differing significantly both between group and 
within group relative to baseline. Finally, Figure 5H shows a switch 
between greater OSA signal at the start of the challenge fol-
lowed by a lower signal during the second half of the task period. 
These examples illustrate the capability of RMANOVA to detect 
variable timing of within and between group differences in physi-
ologic data.
Discussion and conclusions
Advantages of RMANOVA
The results illustrate two advantages of RMANOVA: firstly, no 
prior model of expected response of either signal intensity or timing 
is assumed, and for the type of challenge shown here, a variety of 
significant response patterns was detected by RMANOVA. Sec-
ondly, once a significant effect is found, RMANOVA provides 
an objective, statistically rigorous assessment of the time when 
responses or differences occurred, and the precise response 
pattern. A group difference highlighted by a traditional SPM 
analysis does not differentiate between a group increase vs. no 
change, a group increase vs. a decrease, no change vs. a decrease, 
or a larger increase vs. a smaller increase.
The procedure allows analysis of multiple subjects within multiple 
groups. The within-group and between-group are all performed 
with one analysis, allowing the contributions of subject and group 
factors to be accounted for in the final results.
Note that if all expected responses to the fMRI task are “on/off” 
or boxcar in nature, then the advantages of RMANOVA compared 
with cluster analysis are diminished.
Another advantage lies in processing timetrends from VOI drawn 
in different locations across different subjects. Spatial normaliza-
tion is only accurate to within several millimeters18, and therefore 
small brain structures, such as those in the brainstem cannot be 
accurately depicted on VOI across multiple spatially normalized 
scans. By allowing a group analysis of timetrends from varying 
sites, RMANOVA can be more accurate compared with conven-
tional fMRI analyses in depicting group responses within a particu-
lar structure. For regions such as the dorsal medulla, VOI analysis 
using RMANOVA is particularly helpful for determining group 
patterns.
Disadvantages of RMANOVA
Two disadvantages of RMANOVA relate to defining the VOI. The 
procedure requires manual definition of the VOI, perhaps for each 
subject, or at least for each structure of interest. A second dis-
advantage is that no whole-brain search is performed, and only 
a priori defined areas are studied. For this reason, we believe that a 
combination of a traditional SPM analysis with RMANOVA allows 
for a complete and powerful approach to analysis of fMRI data 
where the time-course of responses is of interest.
The approach does not consider or allow for variations in the 
shape of the HRF. A standard HRF may be used to deconvolve each 
time series, resulting in an inferred neural response time series, or 
a different HRF may be used for different VOI (to account for the 
spatial variation in HRF shape).
Temporal autocorrelation between repeated measures is not 
accounted for, which likely leads to some loss of power. In other 
words, the method does not account for the fact that responses at 
two adjacent time-points are more likely to be related than those at 
two separated time points. Nevertheless, we have found the tech-
nique highlights many patterns of interest, and thus this limitation 
does not negate the sensitivity of the technique. Theoretically, the 
limitation would be greater for signals that change slowly, such that 
adjacent time-points have very similar responses. In such a case, 
that is if smoother, less time-varying responses are expected, a 
model-based approach as in SPM or a time-series regression may 
be better suited to the analysis. Alternatively, for fMRI data in 
particular, pre-whitening could be applied to minimize the impact 
of temporal autocorrelations19.
Procedural disadvantages with the proposed method include the 
requirement for detrending images prior to analysis, the extrac-
tion of the VOI time-trends from the images, and in the example 
presented here, the use of R or SAS. The former requires compu-
tation routines which are typically not included in fMRI analysis 
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software, and the latter requires routines for exporting the data, 
availability of software, and some familiarity with this software.
There are a number of assumptions underlying the RMANOVA 
method, which are fully described above, along with their associ-
ated limitations. As with any statistical model, RMANOVA should 
be used with problems that match those assumptions.
Conclusions
Analyzing timetrends from continuous physiologic measures 
using RMANOVA can highlight temporal patterns of response to 
a challenge not readily apparent using conventional model-based 
approaches. Our research group has used this method extensively 
to assess fMRI and cardio-respiratory responses to physiological 
challenges with complex responses over periods of tens of seconds 
to minutes. RMANOVA allows insight into the precise timing of 
changes from baseline, and response differences between groups. 
For complex paradigms, the technique can be a useful addition to 
conventional model-based approaches.
Data and software availability
F1000Research: Dataset 1. Processed data, as well as the SAS 
code for running each VOI analysis, 10.5256/f1000research.8252.
d11747920
Harvard Dataverse: Macey, Paul. 2016. Pilot fMRI of breath-hold 
in OSA, http://dx.doi.org/10.7910/DVN/EZUMI921
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  Current Referee Status:
Version 2
 29 July 2016Referee Report
doi:10.5256/f1000research.9880.r15277
 Matthew Brett
Henry H. Wheeler, Jr. Brain Imaging Center, University of California, Berkeley, Berkeley, CA, USA
Thanks for the revisions. In particular, thanks for the R code, I think that will make the code from the paper
much more accessible.
I have some minor comments.
In general, can you put the code in typewriter font or similar to differentiate the code and variable names
from the rest of the text?
Page 5 "Although other covariance matrices other than compound sym- metric might in theory be more
suited to the present application, in our tests with SAS we found greatly increased computational time for
minimal differences in results" - can you give any data on that conclusion?
Top of page 6 "ROC SORT DATA= voilib.withingroup; BY group _epoch; RUN;The above code will create
Withingroup and Betweengroup tables in the SAS library voilib."  I think the formatting got messed up?
Page 7: "Violation of the homogeneity of covariance matrices generally results in the overall test having a
higher Type I error rate than nominally set." - can you add a citation?
Page 7-9: I might have missed it, but have you some guidance on the acceptable degree of not-normality
or skewness?  For example, what do you mean by "moderate" or "serious" skew?
Page 9 : Can you add citations for the statements on sphericity?
Page 9: "we suggest a compound symmetric matrix" - can you give more justification for this choice?
Page 9: "Smoothed images were intensity normalized to minimize global effects." - could you be specific
what normalization you used?
Page 10: "For the right mid cingulate (Figure 5F)," - I think you mean Figure 5D.
Page 11: Have you previously defined the abbreviation OSA for Obstructive Sleep Apnea? 
Page 11: "Temporal autocorrelation between repeated measures is not accounted for, which likely leads
to some loss of power." - can you give more detail? Under what circumstances would temporal
autocorrelation lead to excess false positives?
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to some loss of power." - can you give more detail? Under what circumstances would temporal
autocorrelation lead to excess false positives?
Page 11: "Nevertheless, we have found the technique highlights many patterns of interest, and thus this
limitation does not negate the sensitivity of the technique."  - maybe omit the second clause here? I guess
it's possible that the effects you have here are so strong that they overwhelm an insensitive technique.
Thanks again for the revisions.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
 11 July 2016Referee Report
doi:10.5256/f1000research.9880.r14836
 Joke Durnez
Poldrack Lab, Department of Psychology, Stanford University, Stanford, CA, USA
I thank the authors for their careful revision. My comments and questions have been met and I deem this
paper fit for indexation.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Version 1
 04 May 2016Referee Report
doi:10.5256/f1000research.8876.r13203
 Matthew Brett
Henry H. Wheeler, Jr. Brain Imaging Center, University of California, Berkeley, Berkeley, CA, USA
This paper is shows how to apply the SAS "MIXED" procedure to FMRI data from ROIs, presents some
data from this application, and discusses some of the options and diagnostics that this command
provides.
The idea is to do what other packages would call an FIR analysis. You first decide on a time-bin width,
typically one scan, but sometimes more. Call the time bin width B seconds. Then the scan data is labeled
according to how many time bin widths it is after some event onset up until a cutoff of N time-bins.
Usually N * B is equal to the length of the event plus 20 seconds or so to let the hemodynamic response
drop back to baseline. Then the fitting procedure calculates adjusted means for each for the N bins, giving
an evoked response time-course that can simultaneously adjust for other effects in the data, fit in the
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an evoked response time-course that can simultaneously adjust for other effects in the data, fit in the
regression model.
In what follows, I confess I know SPM much better than the other packages, so I'll mainly compare to
SPM.
SPM is rather general, but it does have this capability. The standard procedure would be to fit an "FIR"
model to each subject, giving an estimated signal for each time bin in beta images, with one beta image
for each bin. You then take these time-bin beta images into your second-level model, where you can
adjust for variance covariance effects such as correlation between time-bin values within subjects,
different within-subject variance, and so on.
As you say, using these methods in SPM can be moderately hard, but I'd argue the complexity is
comparable to switching languages from MATLAB to SAS and using SAS to calculate things like adjusted
means, residuals and so on.
How would you expect the results of using the SPM interface (I guess within marsbar) to compare to the
results of using the SAS methods you have here.
I was expecting to see you using either MATLAB or R to do this; MATLAB because SPM already requires
MATLAB, and it's a general programming language, R because it has a variety of procedures for fitting
repeated measures models (see for example 
), is free, open-source,http://www.r-statistics.com/2010/04/repeated-measures-anova-with-r-tutorials/
and, in my experience, is more widely used than SAS in research
communities, including neuroimaging.
I'm afraid I haven't used SAS since the 1980s, so it's hard for me to comment on the details of the SAS
commands.
I found myself skip-reading the actual SAS commands, I don't know how useful they will be for someone
not experienced with SAS. Maybe in-line comments would help?
At various points you recommend options for diagnostics and outlier detection. It would help to have more
detail as to why you recommend those options over others.
Description of procedure, first paragraph "Proportional scaling" is a technical term (at least in SPM-land)
for dividing each scan voxel value by the calculated in-brain mean across voxels for the same scan. That
is now very rarely used SPM, and was never widely used for FMRI.  The standard SPM scaling involves
multiplying each scan in a run by the same scaling factor, that brings the mean of in-brain mean voxel
values to 100.
Assumptions, diagnostic checks, and limitations, first paragraph:
Could you expand on "Violations of independence produce a non-normal distribution of the residuals"?
Options if diagnostic tests fail, first paragraph "but for smaller numbers the model is likely to be robust for
no more than a small amount of skew.". Could you rephrase to something like "For small numbers, even a
small amount of skew will make it unlikely that the model is robust.".  For some reason I found your
original sentence a bit difficult to parse.
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Disadvantages of RMANOVA, third paragraph:
You mention that "Temporal autocorrelation between repeated measures is not accounted for".  Could
you elaborate? I guess you mean that repeated measures variance / covariance adjustments in MIXED
are for the estimates across time bins, not for the autocorrelation between scans. In that case, are you
expecting something like SPM to do better, given that it does adjust for autocorrelation at the first level?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 01 Jul 2016
, UCLA, USAPaul Macey
[Initial comments repeated for both reviewers]
Thanks to the reviewers for their thoughtful comments. We made extensive revisions to the paper,
which should make this method more accessible. The major changes including adding R code for
implementing RMANOVA and diagnostic tests, simplifying some of the SAS commands and
formatting requirements, and clarifying the nature of time series for which the method is applicable.
We did investigate implementing the method in MATLAB, but found that approach to be
cumbersome and limited. While we did not test the method in SPSS, our understanding is that
such implementation is similar to SAS, and relatively straight forward. In R, RMANOVA is
non-trivial, and we settled on a mixed model approach that is equivalent to the one presented in
SAS, but with more limited options should the user wish to try alternative covariance options.
Furthermore, in R there are many options for diagnostic plots and calculations, and we selected
one series of commands and packages that implement all SAS outputs other than studentized
residuals.
In proposing a simplified data format, we decided to expand the scope of the method to include
physiologic signals other than fMRI, such as heart rate, pulse oximetry, and other continuously
acquired signals. We have applied our RMANOVA to these other signals in several publications.
We therefore changed the title of the paper to reflect this broader application.
We updated the “dataverse” repository to include example R and SAS code, and a formatted data
file.
Specific responses to Matthew Brett's comments
The reviewer’s comments are helpful in clarifying how this method fits with other available
approaches.
This paper shows how to apply the SAS "MIXED" procedure to FMRI data from ROIs,
presents some data from this application, and discusses some of the options and
diagnostics that this command provides.
The idea is to do what other packages would call an FIR analysis. You first decide on a
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The idea is to do what other packages would call an FIR analysis. You first decide on a
time-bin width, typically one scan, but sometimes more. Call the time bin width B seconds.
Then the scan data is labeled according to how many time bin widths it is after some event
onset up until a cutoff of N time-bins.
Usually N * B is equal to the length of the event plus 20 seconds or so to let the
hemodynamic response drop back to baseline. Then the fitting procedure calculates
adjusted means for each for the N bins, giving an evoked response time-course that can
simultaneously adjust for other effects in the data, fit in the regression model.
In what follows, I confess I know SPM much better than the other packages, so I'll mainly
compare to SPM.
SPM is rather general, but it does have this capability. The standard procedure would be to
fit an "FIR" model to each subject, giving an estimated signal for each time bin in beta
images, with one beta image for each bin. You then take these time-bin beta images into
your second-level model, where you can adjust for variance covariance effects such as
correlation between time-bin values within subjects, different within-subject variance, and so
on.
As you say, using these methods in SPM can be moderately hard, but I'd argue the
complexity is comparable to switching languages from MATLAB to SAS and using SAS to
calculate things like adjusted means, residuals and so on.
An SPM FIR analysis could replicate the SAS implementation of our timetrend RMANOVA
approach, and we have used FIR in single-group fMRI studies of physiologic challenges.
However, the results of a multi-group FIR quickly become complex since there is a
voxel-level map of significant responses at each time point during the challenge and
recovery. Performing between-group comparisons with FIR requires quite large and
complex design matrices and contrasts. The marsbar toolbox allows extraction of the
timetrend for those contrasts at pre-determined VOI, but to indicate timepoints of significant
within or between group responses, the user would still need to identify these manually from
the bin contrast maps (at least that is my understanding).
We agree that SAS is a complex environment unfamiliar to most neuroimaging researchers.
At the time we originally developed this approach, MATLAB and R did not have the
necessary capabilities, but that has mostly changed. In our revised paper, we present an
implementation in R. We evaluated MATLAB but found no reasonable way to implement the
present type of RMANOVA. In practice, the method is automated, so users don’t need to
work within R or SAS other than running the analyses.
One advantage of SAS over R is the option to easily choose a variety of covariance
matrices. This could be important for experiments where the variability changes over time.
For example, the standard “compound symmetric” (cs) covariance matrix we propose
assumes equal variability at all timepoints including before during and after a task, whereas,
for example, the “compound symmetric heterogenous” (csh) covariance matrix allows for
different variances (and hence standard error estimates) at each timepoint. Theoretically
csh should allow for more accurate models, although we found no major differences for our
physiologic experiments and in our example use cs due to the lower computation needs.
The R implementation does not have the option to choose covariance matrices, but we used
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The R implementation does not have the option to choose covariance matrices, but we used
a random intercept for each subject, which is equivalent to cs.
 
How would you expect the results of using the SPM interface (I guess within marsbar) to
compare to the results of using the SAS methods you have here.
The principal advantage of our technique is that it gives simple results that match the fMRI
time-trend patterns. If a timetrend is higher or lower than the baseline at a timepoint, the
method will indicate whether that increase was significant or not via a timepoint-specific
p-value. If the timetrends for two groups diverge at a timepoint, the method will indicate
whether that group difference is significant, again with a timepoint-specific p value.
 
I was expecting to see you using either MATLAB or R to do this; MATLAB because SPM
already requires MATLAB, and it's a general programming language, R because it has a
variety of procedures for fitting repeated measures models (see for example 
http://www.r-statistics.com/2010/04/repeated-measures-anova-with-r-tutorials/), is free,
open-source, and, in my experience, is more widely used than SAS in research 
communities, including neuroimaging.
I'm afraid I haven't used SAS since the 1980s, so it's hard for me to comment on the details
of the SAS commands.
I found myself skip-reading the actual SAS commands, I don't know how useful they will be
for someone not experienced with SAS. Maybe in-line comments would help?
We have provided an R implementation, and added comments.
 
At various points you recommend options for diagnostics and outlier detection. It would help
to have more detail as to why you recommend those options over others.
We have added additional comments explaining the tests.
 
Description of procedure, first paragraph "Proportional scaling" is a technical term (at least
in SPM-land) for dividing each scan voxel value by the calculated in-brain mean across
voxels for the same scan. That is now very rarely used SPM, and was never widely used for
FMRI.  The standard SPM scaling involves multiplying each scan in a run by the same
scaling factor that brings the mean of in-brain mean voxel values to 100.
We have removed this comment.
Assumptions, diagnostic checks, and limitations, first paragraph:
Could you expand on "Violations of independence produce a non-normal distribution of the
residuals"?
We added some further explanation of independence violations.
 
Options if diagnostic tests fail, first paragraph "but for smaller numbers the model is likely to
be robust for no more than a small amount of skew.". Could you rephrase to something like
"For small numbers, even a small amount of skew will make it unlikely that the model is
robust.". For some reason I found your original sentence a bit difficult to parse.
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robust.". For some reason I found your original sentence a bit difficult to parse.
We agree the original wording was confusing, and we have reworded according to this
suggestion.
Disadvantages of RMANOVA, third paragraph:
You mention that "Temporal autocorrelation between repeated measures is not accounted
for".  Could you elaborate? I guess you mean that repeated measures variance / covariance
adjustments in MIXED are for the estimates across time bins, not for the autocorrelation
between scans. In that case, are you expecting something like SPM to do better, given that
it does adjust for autocorrelation at the first level?
We give more detail in this paragraph. Specifically, we note that if there is a high correlation
between adjacent time points (that is, there is only slow variation), this limitation will be more
prominent. If the response are not expected to change much over time, SPM would be a
better approach. We try to capture this aspect with “variable responses” in the paper title.
 
 
 No competing interests were disclosed.Competing Interests:
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doi:10.5256/f1000research.8876.r13288
 Joke Durnez
Poldrack Lab, Department of Psychology, Stanford University, Stanford, CA, USA
This paper aims to present a different approach to analyzing fMRI time trends.  The idea is to average the
signal overall trials, over subjects (similar to ERP-analysis) and look at the differences between groups
and conditions and especially its interaction with time since onset. Because the trials are clustered within
subjects, the data points are modeled using a mixed model.  
The result is a figure with the average time course per group/condition, with a statistical test comparing
the BOLD signal at each time point.
The main difference between this model and the model in the standard (frequentist, parametric mixed
model) procedure is the specific within-subjects design matrix. The predictor over time in a standard
analysis would be:
[ 0 0 0 1 1 1 0 0 0 1 1 1] o HRF
The predictor over time with the presented approach would be a categorical variable:
[ 0 0 0 1 2 3 0 0 0 1 2 3 ]
The model tested is then BOLD = GROUP + TIME + GROUP*TIME.  Important: TIME is modeled as a
categorical variable, not continuous. Modeling time as a categorical folder allows to test for each time
point separately as a post-hoc test. The results of interest are the post-hoc tests of the interaction effect
between group and time.
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between group and time.
SOME COMMENTS
The focus of the paper is on the post-hoc tests.  These are definitely interesting, but the post-hoc
tests should only be performed if the interaction group*time is significant. It would be interesting to
also have some more detail on the main model (e.g. main effect of time, what does it mean? what
is the interaction?)
 
In my opinion the chunks of code make it hard to read through the paper. It would be easier if the
methods section only describes the different choices/tests/parameters and the code is grouped in
an appendix. Especially code that is just for the purpose of making variables or figures should not
be in the main manuscript.
 
In general, I think SAS is a bad choice. Even though it has definitely one of the best mixed model
implementations, it’s not a typical language at all in neuroimaging. If you want people to use this
procedure, consider having a script in R, matlab or python.
 
I have tried to reproduce the code with the data attached. However, the datasets have different
names and paths. It’s hard to derive what is what…
 
I very much liked the diagnostics, something that is most often lacking in neuroimaging studies.
 
I think the part about missing data could be removed. This problem is non-existing in fMRI.
 
In the results section: “all significant effects were BOLD signal responses”. Poor choice of words.
The outcome variable is the BOLD signal response, not the effect.
 
“the highlighted VOI did show significant overall effects”: significant overall effects of group? of
time? the interaction? all of them?
 
The interpretation given to the time series is the interpretation of a pattern.  However, these tests
are not tests for patterns. For example, the interpretation of the interaction on fig 6E is not
significant on all time points but is interpreted as such. This door is wide open for over interpreting
non-significant results. This is a problem with these point wise comparisons.
 
There are ways to take away the temporal autocorrelation (whitening), which is currently used in
fMRI software. You should mention this when talking about the problem of temporal correlation.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 01 Jul 2016
, UCLA, USAPaul Macey
[Initial comments both reviewers]
Thanks to the reviewers for their thoughtful comments. We made extensive revisions to the paper,
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Thanks to the reviewers for their thoughtful comments. We made extensive revisions to the paper,
which should make this method more accessible. The major changes including adding R code for
implementing RMANOVA and diagnostic tests, simplifying some of the SAS commands and
formatting requirements, and clarifying the nature of time series for which the method is applicable.
We did investigate implementing the method in MATLAB, but found that approach to be
cumbersome and limited. While we did not test the method in SPSS, our understanding is that
such implementation is similar to SAS, and relatively straight forward. In R, RMANOVA is
non-trivial, and we settled on a mixed model approach that is equivalent to the one presented in
SAS, but with more limited options should the user wish to try alternative covariance options.
Furthermore, in R there are many options for diagnostic plots and calculations, and we selected
one series of commands and packages that implement all SAS outputs other than studentized
residuals.
In proposing a simplified data format, we decided to expand the scope of the method to include
physiologic signals other than fMRI, such as heart rate, pulse oximetry, and other continuously
acquired signals. We have applied our RMANOVA to these other signals in several publications.
We therefore changed the title of the paper to reflect this broader application.
We updated the “dataverse” repository to include example R and SAS code, and a formatted data
file.
Specific responses to Joke Durnez's comments
This paper aims to present a different approach to analyzing fMRI time trends.  The idea is to
average the signal overall trials, over subjects (similar to ERP-analysis) and look at the differences
between groups and conditions and especially its interaction with time since onset. Because the
trials are clustered within subjects, the data points are modeled using a mixed model.  
The result is a figure with the average time course per group/condition, with a statistical test
comparing the BOLD signal at each time point.
The main difference between this model and the model in the standard (frequentist, parametric
mixed model) procedure is the specific within-subjects design matrix. The predictor over time in a
standard analysis would be:
[ 0 0 0 1 1 1 0 0 0 1 1 1] o HRF
The predictor over time with the presented approach would be a categorical variable:
[ 0 0 0 1 2 3 0 0 0 1 2 3 ]
The model tested is then BOLD = GROUP + TIME + GROUP*TIME.  Important: TIME is modeled
as a categorical variable, not continuous. Modeling time as a categorical folder allows to test for
each time point separately as a post-hoc test. The results of interest are the post-hoc tests of the
interaction effect between group and time.
 
We appreciate this simplified description of the technique; we have included a synthesis at the
start of the Introduction.
SOME COMMENTS
The focus of the paper is on the post-hoc tests.  These are definitely interesting, but the
post-hoc tests should only be performed if the interaction group*time is significant. It would
be interesting to also have some more detail on the main model (e.g. main effect of time,
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be interesting to also have some more detail on the main model (e.g. main effect of time,
what does it mean? what is the interaction?)
The sequence is to test 1) global fit of the model; if significant then test 2) variable and
interaction level fit; and if significant test 3) post hoc at individual time points. This sequence
was not clear in the original version. We agree that pot hoc assessments at time points are
only valid for significant model-level effects of time (within group) or group*time (between
group), and we have emphasized this point in the revised paper. 
 
In my opinion the chunks of code make it hard to read through the paper. It would be easier
if the methods section only describes the different choices/tests/parameters and the code is
grouped in an appendix. Especially code that is just for the purpose of making variables or
figures should not be in the main manuscript. 
We have simplified the code and proposed input data format, which eliminates some of the
more cumbersome and less relevant code. We did originally have the code in appendices,
but this format did not fit the requirements of this journal. In the revised paper, we added
comments and restructured some sections to improve readability.
 
In general, I think SAS is a bad choice. Even though it has definitely one of the best mixed
model implementations, it’s not a typical language at all in neuroimaging. If you want people
to use this procedure, consider having a script in R, matlab or python.
We now provide an implementation in R, since this software is free and well supported in the
statistical community. We did evaluate RMANOVA in MATLAB, but found no reasonable
approach to replication the implementation we propose.
While SAS is an environment principally familiar to statisticians, the implementation of the
procedure and diagnostic tests is simpler and more comprehensive than R. For that reason,
we have left the SAS code in the paper.
 
I have tried to reproduce the code with the data attached. However, the datasets have
different names and paths. It’s hard to derive what is what…
We simplified the input data format to be a text file with three or four columns. The original
approach of importing from Excel was cumbersome, but with the more logical format users
should find it easier to run the SAS or R commands.  
 
I very much liked the diagnostics, something that is most often lacking in neuroimaging
studies.
We appreciate the comment. We have added explanations, as noted in response to
Matthew Brett.
 
I think the part about missing data could be removed. This problem is non-existing in fMRI.
As noted in response to Matthew Brett , we have expanded the paper to explain how this
RMANOVA approach applies to non-fMRI physiologic data, where missing values are
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RMANOVA approach applies to non-fMRI physiologic data, where missing values are
possible. We have clarified the limitation.
 
In the results section: “all significant effects were BOLD signal responses”. Poor choice of
words. The outcome variable is the BOLD signal response, not the effect.
We revised this introductory paragraph. 
 
“the highlighted VOI did show significant overall effects”: significant overall effects of group?
of time? the interaction? all of them?
We revised the wording in this section.
 
The interpretation given to the time series is the interpretation of a pattern.  However, these
tests are not tests for patterns. For example, the interpretation of the interaction on fig 6E is
not significant on all time points but is interpreted as such. This door is wide open for over
interpreting non-significant results. This is a problem with these point wise comparisons.
The reviewer is correct to note RMANOVA is not identifying patterns, but rather effects at
time points independent of each other. We have changed this terminology.
We have emphasized that the time points will only be assessed post hoc if the
corresponding independent variable is significant within the model. If the group×time
interaction is not significant, the between-group time points will not be considered. If the
time variable is not significant, the within-group time points will not  be considered.
 
There are ways to take away the temporal autocorrelation (whitening), which is currently
used in fMRI software. You should mention this when talking about the problem of temporal
correlation.
We have expanded this paragraph and included a note about whitening.
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